Explore Our Diagnostic Portfolio
Available Tests: 38
Fusion Gene MRD Detection
BCR::ABL1 p210
Quantitative detection of BCR-ABL1 mRNA copy
number is performed using digital PCR, applicable to
97% of CML cases. It can be used for CML diagnosis
and classification, treatment response evaluation,
prognosis assessment, and minimal residual disease
(MRD) monitoring.
BCR::ABL1 p190
Quantitative detection of BCR-ABL1 mRNA copy number
is performed using digital PCR. This assay supports
studies on disease classification, treatment response,
prognosis, and MRD monitoring in CML and ALL.
BCR::ABL1 p230
Quantitative detection of BCR-ABL1 mRNA copy
number is performed using digital PCR. This assay
supports studies on classification, treatment response,
prognosis, and MRD monitoring in CML.
AML::ETO
Quantitative detection of AML1-ETO (RUNX1-RUNX1T1)
mRNA is performed using digital PCR. Supports research
on classification, treatment response, prognosis, and
MRD monitoring in AML, especially AML-M2b.
PML::RARα (L-Type)
Quantitative detection of PML-RARα mRNA is performed
using digital PCR. This assay supports studies on
classification, treatment response, prognosis, and MRD
monitoring in APL.
PML::RARα (S-Type)
Quantitative detection of PML-RARα mRNA is performed
using digital PCR. This assay supports studies on
classification, treatment response, prognosis, and MRD
monitoring in APL.
PML::RARα (V-Type)
Quantitative detection of PML-RARα mRNA is performed
using digital PCR. This assay supports studies on
classification, treatment response, prognosis, and MRD
monitoring in APL.
MLL::AF9
Quantitative detection of MLL fusion transcripts (AF9,
AF6, AF4, AF10, ELL, ENL) is performed using digital PCR.
This assay supports AML and T-ALL studies involving
subtype classification, prognosis, and MRD tracking.
MLL::AF6
Quantitative detection of MLL fusion transcripts (AF9,
AF6, AF4, AF10, ELL, ENL) is performed using digital PCR.
This assay supports AML and T-ALL studies involving
subtype classification, prognosis, and MRD tracking.
MLL::AF4
Quantitative detection of MLL fusion transcripts (AF9,
AF6, AF4, AF10, ELL, ENL) is performed using digital PCR.
This assay supports AML and T-ALL studies involving
subtype classification, prognosis, and MRD tracking.
MLL::AF10
Quantitative detection of MLL fusion transcripts (AF9,
AF6, AF4, AF10, ELL, ENL) is performed using digital PCR.
This assay supports AML and T-ALL studies involving
subtype classification, prognosis, and MRD tracking.
MLL::ELL
Quantitative detection of MLL fusion transcripts (AF9,
AF6, AF4, AF10, ELL, ENL) is performed using digital PCR.
This assay supports AML and T-ALL studies involving
subtype classification, prognosis, and MRD tracking.
MLL::ENL
Quantitative detection of MLL fusion transcripts (AF9,
AF6, AF4, AF10, ELL, ENL) is performed using digital PCR.
This assay supports AML and T-ALL studies involving
subtype classification, prognosis, and MRD tracking.
CBFβ::MYH11
Quantitative detection of CBFβ-MYH11 mRNA copy
number is performed using digital PCR. This assay
supports studies on classification, treatment response,
prognosis, and MRD monitoring in AML.
E2A::PBX1
Quantitative detection of E2A-HLF mRNA copy number
is performed using digital PCR. This assay supports
studies on classification, treatment response, prognosis,
and MRD monitoring in ALL, especially precursor B-ALL.
E2A::HLF
Quantitative detection of E2A-HLF mRNA copy number
is performed using digital PCR. This assay supports
studies on classification, treatment response, prognosis,
and MRD monitoring in ALL, especially precursor B-ALL.
SIL::TAL1
Quantitative detection of SIL-TAL1 mRNA copy number
is performed using digital PCR. This assay supports
studies on classification, treatment response,
prognosis, and MRD monitoring in T-ALL.
TEL::AML1
Quantitative detection of TEL-AML1 mRNA expression
level, which can be used for ALL especially B-ALL
diagnosis and classification, efficacy assessment,
prognosis assessment and MRD monitoring.
DEK::CAN
Quantitative detection of DEK-CAN mRNA copy number
is performed using digital PCR. This assay supports
studies on classification, treatment response, prognosis,
and MRD monitoring in AML. It is also observed in MDS
and CML.
Mutation Detection
WT1 mRNA
Quantitative detection of WT1 mRNA copy number
and its expression relative to ABL1 is performed using
digital PCR. This assay supports studies on treatment
response, prognosis, and MRD monitoring in AL and
CML.
MYD88 L265P
Detection of the MYD88 L265P mutation is performed
using digital PCR. This assay supports studies on
classification, drug guidance, and prognosis in
lymphoplasmacytic lymphoma/Waldenström’s
macroglobulinemia (LPL/WM).
KIT D816V
Detection of C-KIT gene mutations D816V, D816Y,
and D816H is performed using digital PCR. This assay
supports studies on treatment response and prognosis
in AML.
KIT D816Y
Detection of C-KIT gene mutations D816V, D816Y,
and D816H is performed using digital PCR. This assay
supports studies on treatment response and prognosis
in AML.
KIT D816H
Detection of C-KIT gene mutations D816V, D816Y,
and D816H is performed using digital PCR. This assay
supports studies on treatment response and prognosis
in AML.
N822K (A-Type/G-Type)
Detection of the C-KIT N822K mutation is performed
using digital PCR. This assay supports studies on
treatment response and prognosis in CBF-AML.
JAK2 V617F
Detection of the JAK2 V617F mutation is performed
using digital PCR. This assay supports studies on
auxiliary diagnosis, therapeutic monitoring, and
prognosis in myeloproliferative disorders (MPD),
including PV, ET, and IMF.
JAK2/MPL/CALR
Detection of the JAK2/MPL/CALR mutation is performed
using digital PCR. This assay supports studies on
auxiliary diagnosis, therapeutic monitoring, and
prognosis in myeloproliferative disorders (MPD),
including PV, ET, and IMF.
DNMT3A R882
Detection of the DNMT3A R882 mutation is performed
using digital PCR. This assay supports studies on
prognosis in AML.
FLT3 D835, I836
Detection of FLT3 gene mutations D835 and D836
is performed using digital PCR. This assay supports
studies on drug guidance and prognosis in AML.
NPM1 (A-Type/B-Type/D-Type)
Detection of NPM1 gene mutation is performed using
digital PCR. This assay supports studies on prognosis
and MRD monitoring in AML.
IDH1 R132L
Detection of the IDH1 R132L mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.
IDH1 R132V
Detection of the IDH1 R132V mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.
IDH1 R132C
Detection of the IDH1 R132C mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.
IDH1 R132G
Detection of the IDH1 R132G mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.
IDH1 R132H
Detection of the IDH1 R132H mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.
IDH1 R132S
Detection of the IDH1 R132S mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.
IDH2 R140Q
Detection of the IDH2 R140 mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.
IDH2 R172K
Detection of the IDH1 R172 mutation is performed
using digital PCR. This assay supports studies on drug
guidance and prognosis in AML.